Home Page: Cancer Treatment Reviews

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Articles in Press

Review article
Open Access
Multiple Bayesian Network Meta-Analyses to Establish Therapeutic Algorithms for Metastatic Triple Negative Breast Cancer
Published online: September 27, 2022
Hot Topic
Response to “Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias”
Published online: September 23, 2022

View All

Issue Highlights

Review articleOpen Access
GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee
Woopen et al.
Published online: April 30, 2022
Hot Topic
Systematic review of the CUP trials characteristics and perspectives for next-generation studies
Rassy et al.
Published online: May 6, 2022
Anti-tumour TreatmentOpen Access
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
Wei et al.
Published online: May 4, 2022
Review articleOpen Access
The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment
Hone Lopez et al.
Published online: May 7, 2022

COVID-19

Complications of TreatmentOpen Access
SARS-CoV-2 and cancer: Are they really partners in crime?
van Dam et al.
Published online: July 10, 2020
Anti-tumour Treatment
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics
Fares et al.
Published online: June 29, 2020
Hot Topic
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
Fontana et al.
Published online: June 10, 2020
Hot Topic
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Slimano et al.
Published online: June 22, 2020
Hot Topic
Free
Cancer and COVID-19: Unmasking their ties
Addeo et al.
Published online: June 3, 2020
Systematic or Meta-analysis Studies
The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer
Surujballi et al.
Published online: March 23, 2021

Most Read (Last 30 Days)

New Drugs
Open Access
A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)
Published online: April 13, 2022
Hot Topic
Open Access
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?
Published online: September 5, 2022
Anti-tumour Treatment
Open Access
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Published online: March 26, 2020
Systematic or Meta-analysis Studies
Open Access
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis
Published online: September 5, 2022
Anti-tumour Treatment
Open Access
Immunotherapy in non-small cell lung cancer harbouring driver mutations
Published online: March 18, 2021
Anti-tumour Treatment
Open Access
The current clinical landscape of personalized cancer vaccines
Published online: March 24, 2022

Masthead

Current Issue Links

Submit Mobile

Articles in Press

Multiple Bayesian Network Meta-Analyses to Establish Therapeutic Algorithms for Metastatic Triple Negative Breast Cancer

Response to “Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias”

Issue Highlights

GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee

Systematic review of the CUP trials characteristics and perspectives for next-generation studies

The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines

The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment

COVID-19

SARS-CoV-2 and cancer: Are they really partners in crime?

Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics

Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

Cancer and COVID-19: Unmasking their ties

The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

Most Read (Last 30 Days)

A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)

Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis

Immunotherapy in non-small cell lung cancer harbouring driver mutations

The current clinical landscape of personalized cancer vaccines

Masthead

Current Issue Links

Submit Mobile

Explore

Publish

Connect

Articles in Press

Issue Highlights

About

Cancer Treatment Reviews

Metrics

Metrics

COVID-19

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)